Nipro Corporation (NPRRF)

OTCMKTS · Delayed Price · Currency is USD

8.71

-0.10 (-1.14%)

At close: Oct 16, 2026

Market Cap	1.50B -4.3%
Revenue (ttm)	4.11B +2.7%
Net Income	86.57M +144.4%
EPS	0.49 +145.3%
Shares Out	n/a
PE Ratio	17.92
Forward PE	n/a
Dividend	0.20 (2.24%)
Ex-Dividend Date	Sep 29, 2026

Volume	100
Open	8.71
Previous Close	8.81
Day's Range	8.71 - 8.71
52-Week Range	8.71 - 9.40
Beta	0.49
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 10, 2026

About Nipro

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses worldwide. The company offers renal products; interventional products, such as cardiovascular products, endovascular products, and accessories; and hospital products, including hypodermic needles, syringes, IV sets and catheters, 3-way stopcocks, infusion sets, balloon infusers, etc. It also provides cardiopulmonary products comprising oxygenators, cardioplegia heat exchangers, perfusion tubing sets, arterial filte... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1947

Employees 38,593

Stock Exchange OTCMKTS

Ticker Symbol NPRRF

Financial Performance

In fiscal year 2026, Nipro's revenue was 660.54 billion, an increase of 2.47% compared to the previous year's 644.59 billion. Earnings were 13.50 billion, an increase of 164.11%.

Financial numbers in JPY Financial Statements